Zobrazeno 1 - 10
of 442
pro vyhledávání: '"T. Talbott"'
Autor:
Iwanowski, Jay
Publikováno v:
Washington Business Journal; 6/16/95, Vol. 14 Issue 5, p25, 1/9p
Publikováno v:
Baltimore Business Journal; 6/2/95, Vol. 13 Issue 2, p5, 1/9p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
David B. Weiner, Stephan J. Wu, Gary P. Kobinger, Jenna Aviles, Devon J. Shedlock, Gary Wong, Daniel O. Villarreal, Devin J.F. Myles, Jian Yan, Maria A. Croyle, Kendra T. Talbott
Publikováno v:
Molecular Therapy. 21(7):1432-1444
Marburg and Ebola hemorrhagic fevers have been described as the most virulent viral diseases known to man due to associative lethality rates of up to 90%. Death can occur within days to weeks of exposure and there is currently no licensed vaccine or
Publikováno v:
Expert Review of Vaccines. 12:537-554
The human body has developed an elaborate defense system against microbial pathogens and foreign antigens. However, particular microbes have evolved sophisticated mechanisms to evade immune surveillance, allowing persistence within the human host. In
Autor:
Niranjan Y. Sardesai, Jean D. Boyer, Karuppiah Muthumani, Sita Awasthi, Kendra T. Talbott, Devon J. Shedlock, Christine Wilson, David B. Weiner, Stephan J. Wu
Publikováno v:
Human Vaccines & Immunotherapeutics. 8:1668-1681
There is no licensed vaccine or cure for human cytomegalovirus (CMV), a ubiquitous β-herpesvirus infecting 60–95% of adults worldwide. Infection can cause congenital abnormalities, result in severe disease in immunocompromised patients, and is a m
Autor:
Niranjan Y. Sardesai, Colleen E. Lucke, Neil J. Cisper, Amir S. Khan, Lindsey Philipson-Weiner, Kendra T. Talbott, Bernadette Ferraro, David B. Weiner
Publikováno v:
Human Vaccines. 7:120-127
Prostate cancer (PCa) remains a significant public health problem. Current treatment modalities for PCa can be useful, but may be accompanied by deleterious side effects and often do not confer long-term control. Accordingly, additional modalities, s
IL-28B/IFN-λ3 Drives Granzyme B Loading and Significantly Increases CTL Killing Activity in Macaques
Autor:
Matthew P. Morrow, Mark G. Lewis, David B. Weiner, Roberta Toporovski, Amir S. Khan, Jian Yan, Niranjan Y. Sardesai, Devon J. Shedlock, Panyupa Pankhong, Kendra T. Talbott
Publikováno v:
Molecular Therapy. 18:1714-1723
Type III/lambda interferons (IFNs) were discovered less than a decade ago and are still in the process of being characterized. Although previous studies have focused on the function of IFN-lambda 3 (also known as interleukin (IL)-28B) in a small anim
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vern A. Dooley, M. Glaucia Teixeira, Cody T. Talbott, Kathy J. Austin, Kimberly L. Staggs, Thomas R. Hansen, Gregory Johnson
Publikováno v:
Biology of Reproduction. 59:293-297
Interferon-tau (IFN-tau) is released by the conceptus and induces two uterine proteins during early pregnancy: ubiquitin cross-reactive protein (UCRP) and granulocyte chemotactic protein-2 (GCP-2). The present experiments were designed to determine w